RIBOSE4LIFE, LLC – Trademark Portfolio
Entity Type: 16
RIBOSE4LIFE, LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 4 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include EZ ATP. The owner is based in Tacoma, WA.
3411 N 19th St
Tacoma, WA 98406
Showing of trademarks Trademarks
Trademark Classifications
RIBOSE4LIFE, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does RIBOSE4LIFE, LLC have?
RIBOSE4LIFE, LLC has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending, 3 abandoned.
What trademark classes does RIBOSE4LIFE, LLC file in?
RIBOSE4LIFE, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 30 (Staple Foods), Class 32 (Light Beverages), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are RIBOSE4LIFE, LLC's most well-known trademarks?
RIBOSE4LIFE, LLC's registered trademark portfolio includes well-known marks such as EZ ATP. These are among 1 currently registered trademark in the portfolio.
What is RIBOSE4LIFE, LLC's trademark registration success rate?
RIBOSE4LIFE, LLC has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 1 application is pending review.